Archives

Loading Events

Autosomal Dominant Polycystic Kidney Disease (ADPKD): Screening & Diagnosis

Autosomal Dominant Polycystic Kidney Disease (ADPKD): Screening & Diagnosis

This presentation discusses the key screening tools and diagnostic algorithms associated with autosomal dominant polycystic kidney disease (ADPKD), including risk assessment tools to assess for rapid progression.

Location

Inn & Spa at Loretto -Tesuque Room

211 Old Santa Fe Trail
Santa Fe, New Mexico 87501 United States
+ Google Map
(505) 988-5531 View Venue Website

Featured Speakers

Sachin Hajarnis

Sachin Hajarnis, PhD

Nephrology Senior Clinical & Scientific Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Sachin Hajarnis, PhD is a Senior Clinical and Scientific Liaison at Otsuka Pharmaceuticals. Dr Hajarnis has a Bachelors and Masters in Life Sciences from University of Mumbai, India. He obtained a PhD in Biochemistry and Molecular Biology from Colorado State University. Dr Hajarnis joined the University of Texas Southwestern Medical school in Dallas, as a post-doctoral fellow in the department of Nephrology where he performed basic research on various aspects of Polycystic Kidney Disease (PKD). He continued his studies on the role of micro-RNAs in PKD as a Research Scientist for several years before joining his current position at Otsuka.

Rim Hadgu

Rim Hadgu, PharmD, BCPS

Nephrology Clinical & Scientific Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Dr Rim Hadgu is a Nephrology Clinical and Scientific Liaison at Otsuka Pharmaceutical Development and Commercialization. She obtained her Doctor of Pharmacy degree from St. Louis College of Pharmacy. She completed an American Society of Health-System Pharmacists (ASHP)-Accredited PGY1 Pharmacy Residency at Xavier University of Louisiana College of Pharmacy and University Medical Center New Orleans. She also completed an ASHP-Accredited PGY2 Nephrology Pharmacy Residency at Albany College of Pharmacy and Health Sciences. Prior to joining Otsuka in October 2021, she was an Assistant Professor of Pharmacy Practice at Midwestern University College of Pharmacy, Glendale Campus where she delivered lectures, precepted Advanced Pharmacy Practice Experience students as well as PGY1 and PGY2 pharmacy residents. She also practiced as a nephrology clinical pharmacist for two years. Dr Hadgu is a Board Certified Pharmacotherapy Specialist by the Board of Pharmacy Specialties.

*Drs Hajarnis and Hadgu are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).

Registration

This event has been canceled.